Dr. Noemi Baffy, MD
Gastroenterology (Gastroenterology Physician)
161 Marginal Way
Portland, ME 04101
Who else practices at this address →
Cumberland County includes primary care (5% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 268
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
ME license MD22382 · AZ license 50399 -
Internal Medicine Physician
PA license MT200613
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mainehealth Maine Medical Center Portland, ME
- Mainehealth Mid Coast Hospital Brunswick, ME
Medical groups
- Portland Gastroenterology Associates PA (22 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 268
- Services billed
- 2,233
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 251 | 102 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 92 | 91 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 79 | 79 |
| Biopsy of large bowel using a flexible endoscope | 61 | 60 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | 58 |
| Established patient office or other outpatient visit, 20-29 minutes | 56 | 44 |
| Established patient office or other outpatient visit, 30-39 minutes | 21 | 19 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | 19 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | 12 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Portland, ME | 87 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Portland, ME | 59 |
| Pantoprazole Sodium Other prescribers in Portland, ME | 32 |
| Lubiprostone Other prescribers in Portland, ME | 31 |
| Linzess (linaclotide) Other prescribers in Portland, ME | 30 |
| Amitriptyline Hcl Other prescribers in Portland, ME | 25 |
| Famotidine Other prescribers in Portland, ME | 24 |
| Humira(Cf) Pen (adalimumab) Other prescribers in Portland, ME | 18 |
| Colestipol Hcl Other prescribers in Portland, ME | 16 |
| Mesalamine Other prescribers in Portland, ME | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 12 payments worth $420 in total to this clinician.
| Fujifilm Healthcare Americas Corporation | $235 |
|---|---|
| AbbVie Inc. | $47.68 |
| Genzyme Corporation | $43.89 |
| Novo Nordisk Inc | $28.08 |
| Lilly USA, LLC | $25.82 |
| Gilead Sciences, Inc. | $25.52 |
| Janssen Biotech, Inc. | $13.99 |
| Food and Beverage | $420 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $43,200 in research payments for these studies, mostly to the institutions running them.
- Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical Co., Ltd. - A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda Pharmaceuticals U.S.A., Inc. · Recruiting · NCT06581328
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.